Position in OABIW
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$0
+$0 QoQ
Shares Held
12,357
+23.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
4 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in OABIW Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $289,525,211 across 340 Biotechnology names. OABIW ranks #340 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
941,283 | $124,936,492 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,435 | $15,117,977 | |
| 3 | INCY |
Incyte Corp
|
116,069 | $13,157,581 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,094 | $12,529,412 | |
| 5 | CAPR |
Capricor Therapeutics, Inc.
|
402,731 | $9,697,762 | |
| 6 | EXEL |
Exelixis, Inc.
|
175,488 | $9,548,302 | |
| 7 | ORMP |
Oramed Pharmaceuticals Inc.
|
1,910,540 | $9,189,697 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
102,823 | $8,940,459 |
All Filings in OABIW
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 12,357 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | — | 10,048 | Shares | Sole | 2026-05-15 | |
| 2023-09-30 | — | 10,968 | Shares | Sole | 2023-11-15 | |
| 2023-03-31 | — | 16,070 | Shares | Sole | 2023-05-16 | |
| No filing history on record for this holder in this stock. | ||||||